Summary NuVasive, Inc. (NuVasive) is a medical device company which offers an extensive selection of minimally-disruptive surgical products and procedurally-integrated solutions for spine. The company's product portfolio encompasses surgical procedures including transforaminal lumbar interbody fusion (TLIF); posterior lumbar interbody fusion (PLIF); posterior cervical fusion; anterior cervical discectomy and fusion; extreme lateral interbody fusion corpectomy ; and anterior lumbar interbody fusion. Its TLIF nad PLIF are based on maximum access surgery (MAS), a minimally-disruptive surgical platform. NuVasive also offers nerve monitoring systems, and cellular allograft as a bone graft substitute in spinal fusion surgery. The company's products are used for the treatment of indications such as cervical disc degeneration; adult degenerative scoliosis; spondylolisthesis; lumbar degenerative disc disease; lumbar spinal stenosis; and back pain. It markets its products in the Americas, Asia-Pacific and Europe. NuVasive is headquartered in San Diego, California, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company NuVasive, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 NuVasive, Inc. Company Snapshot 6 NuVasive, Inc. Company Overview 6 NuVasive, Inc. Pipeline Products and Clinical Trials Overview 7 NuVasive, Inc. - Pipeline Analysis Overview 9 Business Description 9 Key Facts 9 NuVasive, Inc. - Major Products and Services 10 NuVasive, Inc. Pipeline Products by Development Stage 12 NuVasive, Inc. Pipeline Products Overview 14 Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument 14 Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument Product Overview 14 Armada System 15 Armada System Product Overview 15 AttraX 16 AttraX Product Overview 16 Cerpass Cervical Total Disc Replacement System 17 Cerpass Cervical Total Disc Replacement System Product Overview 17 MAS-PCF 18 MAS-PCF Product Overview 18 MAS-TLIF 19 MAS-TLIF Product Overview 19 NuVasive Reline System 20 NuVasive Reline System Product Overview 20 XL TDR 21 XL TDR Product Overview 21 NuVasive, Inc. - Key Competitors 22 NuVasive, Inc. - Key Employees 23 NuVasive, Inc. - Key Employee Biographies 24 NuVasive, Inc. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Recent Developments 27 NuVasive, Inc., Recent Developments 27 Apr 04, 2016: NuVasive Launches Integrated Global Alignment Platform at BritSpine 2016 27 Mar 09, 2016: NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan 28 Feb 11, 2016: NuVasive Elects Robert F. Friel and Donald J. Rosenberg to Board of Directors 29 Feb 11, 2016: NuVasive Reports Fourth Quarter and Full Year 2015 Financial Results 29 Jan 12, 2016: NuVasive Announces Select Preliminary Full-Year 2015 Financial Results and Reiterates 2016 Outlook 31 Dec 10, 2015: NuVasive Announces Location for New State-of-the-Art Manufacturing Facility 31 Dec 01, 2015: NuVasive Appoints Jason D. Hanson as Executive Vice President, Strategy, Corporate Development and General Counsel 32 Oct 27, 2015: NuVasive Reports Third Quarter 2015 Financial Results 33 Oct 13, 2015: NuVasive to Showcase Integrated Global Alignment Platform at North American Spine Society 30th Annual Meeting 34 Oct 01, 2015: Over 2000 Patients Treated with Ellipse Technologies' MAGEC System 35 Appendix 36 Methodology 36 About GlobalData 36 Contact Us 36 Disclaimer 36
List of Tables
NuVasive, Inc. Pipeline Products and Clinical Trials Overview 7 NuVasive, Inc. Pipeline Products by Equipment Type 7 NuVasive, Inc. Pipeline Products by Indication 8 NuVasive, Inc., Key Facts 9 NuVasive, Inc., Major Products and Services 10 NuVasive, Inc. Number of Pipeline Products by Development Stage 12 NuVasive, Inc. Pipeline Products Summary by Development Stage 13 Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument - Product Status 14 Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument - Product Description 14 Armada System - Product Status 15 Armada System - Product Description 15 AttraX - Product Status 16 AttraX - Product Description 16 Cerpass Cervical Total Disc Replacement System - Product Status 17 Cerpass Cervical Total Disc Replacement System - Product Description 17 MAS-PCF - Product Status 18 MAS-PCF - Product Description 18 MAS-TLIF - Product Status 19 MAS-TLIF - Product Description 19 NuVasive Reline System - Product Status 20 NuVasive Reline System - Product Description 20 XL TDR - Product Status 21 XL TDR - Product Description 21 NuVasive, Inc., Key Employees 23 NuVasive, Inc., Key Employee Biographies 24 NuVasive, Inc., Other Locations 25 NuVasive, Inc., Subsidiaries 25
List of Figures
NuVasive, Inc. Pipeline Products by Equipment Type 8 NuVasive, Inc. Pipeline Products by Development Stage 12
Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected toRead More...
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive tRead More...
Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expeRead More...
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.